199 related articles for article (PubMed ID: 22331238)
1. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
[TBL] [Abstract][Full Text] [Related]
2. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
Winter MA; Guhr KN; Berg GM
Pharmacotherapy; 2012 Jul; 32(7):604-12. PubMed ID: 22576791
[TBL] [Abstract][Full Text] [Related]
3. Estimating creatinine clearance: a meta-analysis.
Wilhelm SM; Kale-Pradhan PB
Pharmacotherapy; 2011 Jul; 31(7):658-64. PubMed ID: 21923452
[TBL] [Abstract][Full Text] [Related]
4. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
Leader WG; Tsubaki T; Chandler MH
Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.
Kaag D
Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495
[TBL] [Abstract][Full Text] [Related]
6. The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.
Park EJ; Pai MP; Dong T; Zhang J; Ko CW; Lawrence J; Crentsil V; Zhang L; Xu NN
Ann Pharmacother; 2012 Mar; 46(3):317-28. PubMed ID: 22395245
[TBL] [Abstract][Full Text] [Related]
7. Estimation of creatinine clearance in morbidly obese patients.
Demirovic JA; Pai AB; Pai MP
Am J Health Syst Pharm; 2009 Apr; 66(7):642-8. PubMed ID: 19299371
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
Ekhart C; Rodenhuis S; Schellens JH; Beijnen JH; Huitema AD
Cancer Chemother Pharmacol; 2009 Jun; 64(1):115-22. PubMed ID: 18989671
[TBL] [Abstract][Full Text] [Related]
9. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
[TBL] [Abstract][Full Text] [Related]
10. Role of lean body mass for estimation of glomerular filtration rate in patients with chronic kidney disease with various body mass indices.
Ozmen S; Kaplan MA; Kaya H; Akin D; Danis R; Kizilkan B; Yazanel O
Scand J Urol Nephrol; 2009; 43(2):171-6. PubMed ID: 18979280
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit.
Snider RD; Kruse JA; Bander JJ; Dunn GH
Pharmacotherapy; 1995; 15(6):747-53. PubMed ID: 8602383
[TBL] [Abstract][Full Text] [Related]
13. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
Apperloo JJ; Gerlag PG; Beerenhout CH; Vader HL
Ned Tijdschr Geneeskd; 2007 May; 151(18):1016-23. PubMed ID: 17508688
[TBL] [Abstract][Full Text] [Related]
14. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
Brown DL; Masselink AJ; Lalla CD
Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
[TBL] [Abstract][Full Text] [Related]
15. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J
Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853
[TBL] [Abstract][Full Text] [Related]
16. Standardization of p-creatinine assays and use of lean body mass allow improved prediction of calculated glomerular filtration rate in adults: a new equation.
Nyman U; Björk J; Sterner G; Bäck SE; Carlson J; Lindström V; Bakoush O; Grubb A
Scand J Clin Lab Invest; 2006; 66(6):451-68. PubMed ID: 17000553
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: cockcroft-gault and modification of diet in renal disease.
Golik MV; Lawrence KR
Pharmacotherapy; 2008 Sep; 28(9):1125-32. PubMed ID: 18752383
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
[TBL] [Abstract][Full Text] [Related]
19. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.
Verhave JC; Fesler P; Ribstein J; du Cailar G; Mimran A
Am J Kidney Dis; 2005 Aug; 46(2):233-41. PubMed ID: 16112041
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
Herrington JD; Tran HT; Riggs MW
Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
